Raymond James Financial
TMDX icon

Raymond James Financial’s Transmedics TMDX Stock Holding History

Raymond James Financial’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Sell
64,481
-50,554
-44% -$4.28M ﹤0.01% 2863
2026
Q1 		$11.1M Buy
115,035
+2,503
+2% +$326K ﹤0.01% 1931
2025
Q4 		$13.7M Sell
112,532
-448
-0.4% -$56.2K ﹤0.01% 1721
2025
Q3 		$12.7M Sell
112,980
-78,369
-41% -$9.17M ﹤0.01% 1742
2025
Q2 		$25.6M Buy
191,349
+45,956
+32% +$5.05M 0.01% 1178
2025
Q1 		$9.78M Buy
145,393
+83,722
+136% +$5.76M ﹤0.01% 1827
2024
Q4 		$3.85M Buy
+61,671
New +$5.74M ﹤0.01% 2485

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Raymond James Financial's TMDX Position: Q2 2026 in Review

Raymond James Financial reduced its Transmedics (TMDX) stake by 44% in Q2 2026, selling an estimated $4.28M and leaving 64,481 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2863.

Raymond James Financial first reported a position in TMDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.6M in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Raymond James Financial held 64,481 shares of Transmedics worth $4.28M as of Q2 2026.
  • Raymond James Financial sold 50,554 Transmedics shares in Q2 2026, an estimated $4.28M.
  • Transmedics made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2863 holding.
  • Raymond James Financial first reported a position in Transmedics in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Transmedics position peaked at $25.6M in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.